Rocuronium Bromide Injection
Product Images NDC 72572-650

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 72572-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium Bromide Chemical Structure (Rocuronium Bromide Injection 1)

FDA Label Image

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 10)

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 10)
This is a description of Rocuronium Bromide Injection, which is indicated for intravenous use as a paralyzing agent. The injection contains 10mg/mL of rocuronium bromide and should only be administered intravenously.*
FDA Label Image

Layout 1 (Rocuronium Bromide Injection 11)

Layout 1 (Rocuronium Bromide Injection 11)
This text appears to be a product label or packaging containing a Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP), and a lot code (LOT). It is possible that this information is related to tracking and managing inventory or purchase orders.*
FDA Label Image

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 2)

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 2)
The text provides some numerical values that seem to refer to age ranges. The first value is "65yrs," indicating a range of individuals who are 65 years old or older. The second value is "5912," which is unclear without further context but could be a code or identification number. The third line includes the character ">" followed by "45 912," possibly indicating a cutoff or threshold for a certain age range. The fourth and final line provides an age range of "18-64 yrs." Overall, this text is not particularly useful or informative without additional context.*
FDA Label Image

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 3)

FDA Label Image

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Bromide Injection 4)

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Bromide Injection 4)
This is a list of durations or time intervals represented in minutes: 30, 20, and 10.*
FDA Label Image

72572-650-01 (Rocuronium Bromide Injection 5)

72572-650-01 (Rocuronium Bromide Injection 5)
This is a drug label for Rocuronium, a medication used for general anesthesia during surgery. It is a paralyzing agent that is administered through an injection into the veins. The vial contains 50mg/5mL of the medicine, and should only be used by medical professionals. The label gives important information such as the NDC code, dosage instructions, and warnings.*
FDA Label Image

72572-650-10 (Rocuronium Bromide Injection 6)

72572-650-10 (Rocuronium Bromide Injection 6)
PLB503-CIV/1 is a paralyzing agent that can cause respiratory arrest. Facilities with artificial respiration equipment must be immediately available. Each mL of this sterile, nonpyrogenic solution contains 10 mg of rocuronium bromide, 2 mg of sodium acetate, and 3.3 mg of sodium chloride, adjusted to a pH of 4 with acetic acid and/or sodium hydroxide. This drug should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F) and should not be frozen. It can be used within 60 days if kept at room temperature and within 30 days if opened. This medication does not contain natural rubber latex. Dosage instructions can be found in the product insert. This drug is a 50 mg/5 mL (10 mg/mL) injection and is available in 10 x 5 mL multiple-dose vials.*
FDA Label Image

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 7)

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 7)
This text is a label of a medicine which is Rocuronium Bromide Injection and it contains 10 mg/mL. It is to be used only for Intravenous purposes and it is classified as a paralyzing agent.*
FDA Label Image

72572-651-01 (Rocuronium Bromide Injection 8)

72572-651-01 (Rocuronium Bromide Injection 8)
This is a description of a 100mg/10mL Rocuronium Bromide Injection in a 10mL multiple dose vial for intravenous use only. It includes an NDC number. This product is prescription only.*
FDA Label Image

72572-651-10 (Rocuronium Bromide Injection 9)

72572-651-10 (Rocuronium Bromide Injection 9)
This is a description of a medication called PLB504-CIV/1. It contains a paralyzing agent called rocuronium bromide, sodium acetate, and sodium chloride. It is used intravenously and must be stored in a refrigerator. This medication can cause respiratory arrest, so facilities for artificial respiration must be immediately available. The container closure is not made with natural rubber latex. The usual dosage instructions can be found in the package insert. It comes in a package of ten 10 mL multiple dose vials.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.